Literature DB >> 27593359

Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic?

Russell E Lewis1.   

Abstract

Entities:  

Keywords:  KPC carbapenemase; combination therapy; meropenem; synergy

Mesh：

Substances：

Year:  2016        PMID： 27593359      PMCID： PMC5354235          DOI： 10.1080/21505594.2016.1231756

Source DB:  PubMed          Journal:  Virulence        ISSN： 2150-5594            Impact factor:   5.882


× No keyword cloud information.
  12 in total

Review 1.  Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?

Authors:  G L Daikos; A Markogiannakis
Journal:  Clin Microbiol Infect       Date:  2011-06-02       Impact factor: 8.067

Review 2.  Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies.

Authors:  Ting-Chao Chou
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Francesco Giuseppe De Rosa; Maddalena Giannella; Daniele Roberto Giacobbe; Matteo Bassetti; Angela Raffaella Losito; Michele Bartoletti; Valerio Del Bono; Silvia Corcione; Giuseppe Maiuro; Sara Tedeschi; Luigi Celani; Chiara Simona Cardellino; Teresa Spanu; Anna Marchese; Simone Ambretti; Roberto Cauda; Claudio Viscoli; Pierluigi Viale
Journal:  J Antimicrob Chemother       Date:  2015-04-21       Impact factor: 5.790

Review 4.  Options for treating carbapenem-resistant Enterobacteriaceae.

Authors:  Petros I Rafailidis; Matthew E Falagas
Journal:  Curr Opin Infect Dis       Date:  2014-12       Impact factor: 4.915

5.  Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?

Authors:  Valerio Del Bono; Daniele Roberto Giacobbe; Anna Marchese; Andrea Parisini; Carmen Fucile; Erika Coppo; Valeria Marini; Antonio Arena; Alexandre Molin; Antonietta Martelli; Angelo Gratarola; Claudio Viscoli; Paolo Pelosi; Francesca Mattioli
Journal:  Virulence       Date:  2016-07-18       Impact factor: 5.882

Review 6.  Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance.

Authors:  Johann D D Pitout; Patrice Nordmann; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2015-07-13       Impact factor: 5.191

7.  Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens.

Authors:  Zubair A Qureshi; David L Paterson; Brian A Potoski; Mary C Kilayko; Gabriel Sandovsky; Emilia Sordillo; Bruce Polsky; Jennifer M Adams-Haduch; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2012-01-17       Impact factor: 5.191

8.  Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy.

Authors:  Mario Tumbarello; Pierluigi Viale; Claudio Viscoli; Enrico Maria Trecarichi; Fabio Tumietto; Anna Marchese; Teresa Spanu; Simone Ambretti; Francesca Ginocchio; Francesco Cristini; Angela Raffaella Losito; Sara Tedeschi; Roberto Cauda; Matteo Bassetti
Journal:  Clin Infect Dis       Date:  2012-07-02       Impact factor: 9.079

9.  Impact of various conditions on the efficacy of dual carbapenem therapy against KPC-producing Klebsiella pneumoniae.

Authors:  Dora E Wiskirchen; Jared L Crandon; David P Nicolau
Journal:  Int J Antimicrob Agents       Date:  2013-04-21       Impact factor: 5.283

Review 10.  Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art.

Authors:  Nicola Petrosillo; Maddalena Giannella; Russell Lewis; Pierluigi Viale
Journal:  Expert Rev Anti Infect Ther       Date:  2013-02       Impact factor: 5.091
View more
  1 in total

1.  Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae.

Authors:  Yun Liao; Guang-Hui Hu; Yun-Fei Xu; Jian-Ping Che; Ming Luo; Hai-Min Zhang; Bo Peng; Xu-Dong Yao; Jun-Hua Zheng; Min Liu
Journal:  Exp Ther Med       Date:  2017-01-16       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.